Open AccessCost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia
BloodPeer ReviewedJan Philipp Bewersdorf +62022Journals
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support